VentureBeat

Miracor Medical Systems Begins European Launch of Its Next-Generation PICSO® Impulse System, Designed to Reduce Severe Heart Attack Impairment When Used as an Adjunct Therapy ...

Company appoints Cajetan von König as Director of Sales and Marketing VIENNA–(BUSINESS WIRE)–July 22, 2014– Miracor Medical Systems announced today the successful launch of its next-generation PICSO ® ...
TCTMD

Miracor Medical Systems begins European launch of its next-generation PICSO® Impulse System

designed to reduce severe heart attack impairment when used as an adjunct therapy with angioplasty in acute STEMI and NSTEMI patients. Company appoints Cajetan von König as Director of Sales and ...
TCTMD

New clinical trial results for Miracor’s PICSO® Impulse System in Acute Myocardial Infarction will be reported at ‘TCT 2014’

VIENNA, Austria - Miracor Medical Systems announced today that results from the ‘Prepare RAMSES’ clinical trial will be disclosed at ‘TCT 2014’ in Washington, D.C. The Prepare RAMSES trial was a ...
Business Wire

Miracor Medical Granted FDA Breakthrough Device Designation for the PiCSO Impulse System

AWANS, Belgium--(BUSINESS WIRE)--Miracor Medical SA (Miracor Medical) has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its PiCSO ® Impulse System for ...
Business Wire

Miracor Announces Positive Interim Clinical Data with Novel PiCSO® Impulse System for AMI Patients

VIENNA--(BUSINESS WIRE)--Miracor Medical Systems GmbH (Miracor) announced today that interim clinical data presented earlier this month at EuroPCR 2017 in Paris demonstrated significant reductions in ...